Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Longevity Health Holdings ( (XAGE) ) just unveiled an announcement.
Longevity Health Holdings, Inc. announced an amendment to its Agreement and Plan of Merger with 20/20 Biolabs, Inc., extending the due diligence deadline to July 8, 2025. This amendment allows more time for the completion of due diligence, but if not extended further, the merger agreement will automatically terminate on the new deadline, impacting the company’s strategic plans and stakeholder expectations.
More about Longevity Health Holdings
Average Trading Volume: 621,445
Technical Sentiment Signal: Sell
Current Market Cap: $2.93M
Learn more about XAGE stock on TipRanks’ Stock Analysis page.